Akorn Sodium Chloride Ophthalmic Ointment Recalled Due to Manufacturing Deviations
Akorn Inc. is recalling all lots of Sodium Chloride Ophthalmic Ointment 5% nationwide due to manufacturing practice deviations. The company ceased operations and could not continue stability studies required to verify the product's safety and effectiveness.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. The recall is based on manufacturing practice deviations and inability to complete required stability studies, making the hazard theoretical rather than confirmed, warranting a Moderate severity score per the rubric.
Plain-English summary
Akorn Inc., a pharmaceutical manufacturer located in Lake Forest, Illinois, is recalling all lots of Sodium Chloride Ophthalmic Ointment, USP 5% (3.5g tubes). The product was distributed nationwide throughout the United States and Puerto Rico.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. Specifically, Akorn went out of business and consequently was unable to continue the stability studies mandated by FDA regulations. Stability studies are critical for demonstrating that pharmaceutical products remain safe and effective throughout their shelf life.
Without the ability to complete these required stability studies, the firm cannot provide assurance of the product's continued quality and performance. This lack of demonstrated stability led the FDA to classify this as a Class II recall.
The recalled product
- Product
- Sodium Chloride Ophthalmic Ointment, USP, 5%, 3.5g tubes, Manufactured by: Akorn Inc., Lake Forest, IL 60045. ALL NDCs
- Manufacturer
- Akorn, Inc.
- Category
- Drug — Ophthalmic
- Hazard
- manufacturing-deviation
- unverified-stability
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lots
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27